Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer
Niama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, et al.
Cancer Letters (2019) Vol. 459, pp. 186-191
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial
Arrigo F.G. Cicero, Federica Fogacci, Marilisa Bove, et al.
European Journal of Nutrition (2020) Vol. 60, Iss. 2, pp. 655-663
Closed Access | Times Cited: 103
Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health
Camila Fontoura Acosta Ribeiro, Gislaine Greice de Oliveira Silva Silveira, Elizabete de Souza Cândido, et al.
ACS Infectious Diseases (2020) Vol. 6, Iss. 10, pp. 2544-2559
Closed Access | Times Cited: 84
Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products
Bangyan Li, Xiaoyu Xu, Ren‐You Gan, et al.
Foods (2019) Vol. 8, Iss. 10, pp. 440-440
Open Access | Times Cited: 82
Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism
Jianjun Liu, Jiayi Sun, Jiangkun Yu, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors
Lili Li, Jiajian Ye
Medicine (2020) Vol. 99, Iss. 37, pp. e21788-e21788
Open Access | Times Cited: 49
Impaired Intestinal Akkermansia muciniphila and Aryl Hydrocarbon Receptor Ligands Contribute to Nonalcoholic Fatty Liver Disease in Mice
Zunji Shi, Hehua Lei, Gui Chen, et al.
mSystems (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 48
Alterations in intestinal butyrate-producing Streptococcus and Veillonella species are associated with the severity of hepatitis E
Yanfei Chen, Haiyan Shi, Haifeng Lu, et al.
(2025)
Closed Access
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Sana Raza, Sangam Rajak, Baby Anjum, et al.
Hepatoma Research (2019) Vol. 2019
Open Access | Times Cited: 44
Drug delivery of pH-Sensitive nanoparticles into the liver cancer cells
Maryam Saadat, Farid Mostafaei, Somayeh Mahdinloo, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 63, pp. 102557-102557
Closed Access | Times Cited: 38
Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease
Zunji Shi, Gui Chen, Zheng Cao, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 13, pp. 3982-3991
Closed Access | Times Cited: 32
Structural Insights into Amelioration Effects of Quercetin and Its Glycoside Derivatives on NAFLD in Mice by Modulating the Gut Microbiota and Host Metabolism
Zunji Shi, Ce Zhang, Hehua Lei, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 46, pp. 14732-14743
Closed Access | Times Cited: 23
Dietary sanguinarine ameliorates growth impairment and intestinal dysfunction in Ctenopharyngodon idellus fed a high cottonseed meal diet
Yong Shi, Yuanxiang Liu, Kai Xie, et al.
Aquaculture (2023) Vol. 576, pp. 739864-739864
Closed Access | Times Cited: 13
Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota–bile acid–farnesoid X receptor axis
Hongshan Li, Yingfei Xi, Xin Xin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 124, pp. 109915-109915
Open Access | Times Cited: 34
Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
Lihong He, Dun-Han Yao, Lingyun Wang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 31
Diet and gut microbiome in fatty liver and its associated liver cancer
Yasi Pan, Xiang Zhang
Journal of Gastroenterology and Hepatology (2021) Vol. 37, Iss. 1, pp. 7-14
Open Access | Times Cited: 25
Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
Imaad Said, Hassan Ahad, Adnan Said
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 5, pp. 947-958
Open Access | Times Cited: 14
Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma
Rong Liu, Mingping Qian, Ying‐Yu Cui
Metabolism (2023) Vol. 147, pp. 155665-155665
Closed Access | Times Cited: 7
Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota
Kai Kang, Yue Sun, Dan Pan, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 16
Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
Małgorzata Moszak, Monika Szulińska, Marta Walczak‐Gałęzewska, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 4, pp. 1616-1616
Open Access | Times Cited: 14
Intestinal microecology: A crucial strategy for targeted therapy of liver diseases
Zeng-Rui Chen, Shuifang Jin, Weibin Ma, et al.
Hepatobiliary & pancreatic diseases international (2021) Vol. 20, Iss. 5, pp. 499-500
Closed Access | Times Cited: 12
The role of the gut-liver axis in modulating non-alcoholic fatty liver disease through dietary patterns and microecological agents
Yucheng Fang, Ziyang Fang, Ziwei Li, et al.
Food Bioscience (2023) Vol. 56, pp. 103335-103335
Closed Access | Times Cited: 4
Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
Larisse Longo, Pabulo Henrique Rampelotto, Eduardo Cremonese Filippi–Chiela, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 12, pp. 2052-2070
Open Access | Times Cited: 11
Intestinal Microecology: An Important Target for Chinese Medicine Treatment of Non-alcoholic Fatty Liver Disease
Hongshan Li, Yiyang Hu
Chinese Journal of Integrative Medicine (2020) Vol. 26, Iss. 10, pp. 723-728
Closed Access | Times Cited: 11
Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases
Ulrich Desselberger
Viruses (2021) Vol. 13, Iss. 8, pp. 1601-1601
Open Access | Times Cited: 7
Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
Valentina Liakina, Sandra Strainienė, Ieva Stundienė, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 7, pp. 1277-1290
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top